Skip to main content

Table 2 Treatment cost for each stage and alternative

From: Cost-effectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru

  Stage 1 Stage 2 Stage 3a Stage 3b Stage 4
Diabetic patient (D) Non-diabetic patient (ND) D ND D ND D ND D ND
Cohort distribution
 Proportion of diabetic patients within stage (%) 51 49 42 58 29 71 24 76 22 78
 Number of diabetic patients within stage (n) 1833 1781 2109 2890 2407 6026 536 1671 245 856
 Proportion of patients in each stagea (%) 18   25   41   11   5  
Treatment cost intervention (USD)b
 Outpatient visits 315 315 315 315 340 340 439 370 1018 840
 Laboratory tests 38 34 38 34 69 62 270 197 344 297
 Drugs 47 43 47 43 47 43 118 84 335 280
 Hospital overhead 20 20 20 20 20 20 40 40 40 40
 Total 420 412 420 412 476 464 867 691 1736 1456
Annual cost per patient for each stagea 416   415   468   734   1519  
Annual cost per patientc 531          
Treatment cost standard of care (USD)b
 Outpatient visits 15   15   15   30   30  
 Laboratory test 28   28   28   28   28  
 Total 43   43   43   58   58  
Annual cost per patientc 45          
  1. aValue corresponds to each stage, groups across diabetes status
  2. bAll costing data was rounded to the closest integer
  3. cValue corresponds to all stages and diabetes status